(Q33250633)

24 July 2017

Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness (English)

1 reference

24 July 2017

1 reference

10

Patricia K Donahoe

1 reference

24 July 2017

Paul P Szotek

1

1 reference

24 July 2017

Rafael Pieretti-Vanmarcke

2

1 reference

24 July 2017

Peter T Masiakos

3

1 reference

24 July 2017

Daniela M Dinulescu

4

1 reference

24 July 2017

Denise Connolly

5

1 reference

24 July 2017

Rosemary Foster

6

1 reference

24 July 2017

David Dombkowski

7

1 reference

24 July 2017

Frederic Preffer

8

1 reference

24 July 2017

David T Maclaughlin

9

1 reference

24 July 2017

language of work or name

English

0 references

publication date

18 July 2006

1 reference

Proceedings of the National Academy of Sciences of the United States of America

24 July 2017

1 reference

24 July 2017

103

1 reference

24 July 2017

11154-11159

1 reference

24 July 2017

30

1 reference

Müllerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Müllerian duct regression

24 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1544057

Characterization of a side population of cancer cells from human gastrointestinal system

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1544057

Stem cell niche: structure and function

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1544057

Cancer stem cell characteristics in retinoblastoma.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1544057

21 June 2018

Cancer statistics, 2005

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1544057

Will cancer stem cells provide new therapeutic targets?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1544057

A distinct "side population" of cells with high drug efflux capacity in human tumor cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1544057

Inhibition of ABCB1 (MDR1) and ABCB4 (MDR3) expression by small interfering RNA and reversal of paclitaxel resistance in human ovarian cancer cells.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1544057

Stem cell origin of cancer and differentiation therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1544057

Origin of germ cells and formation of new primary follicles in adult human ovaries

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1544057

Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1544057

Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1544057

Further evidence favoring the concept of the stem cell in ascites tumors of rats

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1544057

Prospective identification of tumorigenic breast cancer cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1544057

Lineage-negative side-population (SP) cells with restricted hematopoietic capacity circulate in normal human adult blood: immunophenotypic and functional characterization

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1544057

Overexpression of human phosphoglycerate kinase 1 (PGK1) induces a multidrug resistance phenotype

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1544057

Stem-cell origin of metastasis and heterogeneity in solid tumours

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1544057

Multidrug resistance in cancer: role of ATP-dependent transporters

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1544057

Stem cells, cancer, and cancer stem cells

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1544057

A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1544057

Mullerian inhibiting substance inhibits ovarian cell growth through an Rb-independent mechanism

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1544057

Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1544057

Biochemistry of multidrug resistance mediated by the multidrug transporter

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1544057

Evolution of tumor cell heterogeneity during progressive growth of individual lung metastases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1544057

On the genesis and regulation of cellular heterogeneity in malignant tumors.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1544057

Recent progress in ovarian cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1544057

Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1544057

Metallothionein gene expression and resistance to cisplatin in human ovarian cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1544057

An immunoassay to detect human müllerian inhibiting substance in males and females during normal development

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1544057

Leukemia: stem cells, preleukemia and cure

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1544057

The production of Mullerian inhibiting substance by the fetal, neonatal and adult rat.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1544057

A brief history of the pathology of the gonads.

21 June 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0603672103

21 January 2018

Cancer statistics, 1997.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0603672103

Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0603672103

Recombinant human Mullerian inhibiting substance inhibits long-term growth of MIS type II receptor-directed transgenic mouse ovarian cancers in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0603672103

Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0603672103

A phase II study of the MDR inhibitor biricodar (INCEL, VX-710) and paclitaxel in women with advanced ovarian cancer refractory to paclitaxel therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0603672103

Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1544057

New approaches for high-yield purification of Müllerian inhibiting substance improve its bioactivity

31 October 2018

1 reference

PubMed

12 December 2020

A graded organ culture assay for the detection of Mullerian inhibiting substance

1 reference

PubMed

12 December 2020

Mullerian inhibiting substance reduction of colony growth of human gynecologic cancers in a stem cell assay

1 reference

PubMed

12 December 2020

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.0603672103

1 reference

24 July 2017

0 references

1 reference

24 July 2017

1 reference